GlassScriptPhysician profile
Niraj V Parekh
NPI 1043416498
$89,627.49
in general payments reported to CMS, 2019-2025
43 companies · $26K in 2025
The $26K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $8,523 · 2021: $2,633 · 2022: $11K · 2023: $4,123 · 2024: $25K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $15K · Food and Beverage: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,750 · Travel and Lodging: $1,802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,150.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $14,850.00 |
| Food and Beverage | $12,583.70 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,750.00 |
| Travel and Lodging | $1,801.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $30,915.60 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Shockwave Medical, INC | $24,173.50 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $18,389.32 | 2019-2025 | Mitraclip, Amplatzer Amulet, Xience Skypoint |
| Medtronic, INC. | $6,437.80 | 2022-2025 | Symplicity G3, Corevalve Evolut R, Valiant Captivia |
| Boston Scientific Corporation | $2,997.34 | 2019-2025 | Watchman Flx, Watchman Access System, Ranger |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,108.16 | 2019-2025 | Lifevest |
| Abiomed | $575.02 | 2021-2023 | Impella |
| Novartis Pharmaceuticals Corporation | $451.40 | 2019-2025 | |
| Pfizer INC. | $447.51 | 2019-2025 | |
| Philips North America LLC | $424.60 | 2019-2024 | (9148) Ice 3d |
| E.R. Squibb & Sons, L.L.C. | $373.81 | 2019-2025 | Camzyos, Eliquis |
| Inari Medical, INC. | $323.29 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $304.31 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Medtronic Vascular, INC. | $276.51 | 2019-2020 | |
| Penumbra, INC. | $271.53 | 2019-2024 | Indigo System |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $243.98 | 2019-2022 | |
| Cardiva Medical, INC. | $234.33 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Stryker Corporation | $197.47 | 2025 | Limflow System, Artix Mt |
| Chiesi USA, INC. | $190.25 | 2021-2025 | Kengreal |
| Cvrx, INC. | $177.68 | 2021-2025 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $133.92 | 2021-2023 | Verquvo |
| Bard Peripheral Vascular, INC. | $132.84 | 2021-2025 | Crosser Iq, Lutonix Drug Coated Balloon |
| Ekos Corporation | $89.49 | 2019 | |
| Atricure, INC. | $78.94 | 2023-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $76.04 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $74.43 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $71.04 | 2020-2022 | |
| Jenavalve Technology, INC. | $66.88 | 2025 | |
| Novo Nordisk INC | $64.78 | 2024-2025 | Ozempic, Wegovy |
| Daiichi Sankyo INC. | $41.51 | 2022-2023 | Injectafer |
| Cardiovascular Systems INC. | $36.29 | 2022 | |
| Tactile Systems Technology INC | $35.30 | 2019-2020 | |
| Imperative Care, INC | $24.26 | 2024 | Symphony Catheter |
| Portola Pharmaceuticals, LLC | $24.07 | 2019 | |
| Glaxosmithkline, LLC. | $23.69 | 2025 | Shingrix |
| Biosense Webster, INC. | $21.72 | 2021 | |
| Becton, Dickinson and Company | $21.20 | 2024 | Crosser Iq |
| Scpharmaceuticals INC. | $19.28 | 2025 | |
| Cordis US Corp. | $18.53 | 2023 | Zephyr |
| Kiniksa Pharmaceuticals, LTD. | $17.19 | 2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $15.44 | 2022 | |
| Gilead Sciences, INC. | $13.79 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $13.45 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niraj Parekh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.